Klein R, Wiebel M, Engelhart S, Berg P A
Medizinische Klinik, University of Tübingen, Germany.
Clin Exp Immunol. 1993 May;92(2):308-16. doi: 10.1111/j.1365-2249.1993.tb03397.x.
Anti-M2 antibodies in primary biliary cirrhosis (PBC) have been shown to react with the alpha-ketoacid dehydrogenase complex of the inner mitochondrial membrane consisting of six epitopes (E2 subunit of the pyruvate dehydrogenase complex (PDC), 70 kD; protein X of the PDC, 56 kD; alpha-ketoglutarate dehydrogenase complex, 52 kD; branched-chain alpha-ketoacid dehydrogenase, 52 kD; E1 alpha subunit of PDC, 45 kD; and E1 beta-subunit of PDC, 36 kD). These epitopes are also present in the M2 fraction which is a chloroform extract from beef heart mitochondria. The E2 subunit of the PDC at 70 kD (M2a), especially, is a major target epitope which is recognized by about 85% of all PBC sera. However, analysing sera from 28 patients with active pulmonary tuberculosis it became evident that 12 (43%) also recognized the PDC-E2 subunit (M2a), as shown by Western blotting using the M2 fraction, the purified PDC, and the recombinant PDC-E2. In contrast, only two of 82 patients with other bacterial and viral infections including 25 patients with Escherichia coli infections reacted with the PBC-specific epitope at 70 kD. Naturally occurring mitochondrial antibodies (NOMA) were present in 54% of the patients with tuberculosis and in 50% of patients with other infectious disorders. They recognized either a determinant at 65 kD (epsilon) or at 60/55 kD (zeta/eta). None of the sera from 100 blood donors had anti-M2 but 14 had NOMA. Testing anti-M2 and NOMA-positive marker sera by Western blotting against membrane fractions derived from mycobacteria and E. coli it could be shown that--like mammalian mitochondria--they contain both the PBC-specific M2 antigen as well as the non-PBC-specific naturally occurring mitochondrial antigen system (NOMAg). The observation that PBC-specific antibodies were preferentially induced in patients suffering from a mycobacterial infection may provide some new clues to the still unknown etiology of PBC.
原发性胆汁性肝硬化(PBC)中的抗M2抗体已被证明可与线粒体内膜的α-酮酸脱氢酶复合体发生反应,该复合体由六个表位组成(丙酮酸脱氢酶复合体(PDC)的E2亚基,70kD;PDC的蛋白X,56kD;α-酮戊二酸脱氢酶复合体,52kD;支链α-酮酸脱氢酶,52kD;PDC的E1α亚基,45kD;以及PDC的E1β亚基,36kD)。这些表位也存在于M2组分中,M2组分是从牛心线粒体中提取的氯仿提取物。尤其是70kD的PDC的E2亚基(M2a),是一个主要的靶表位,约85%的PBC血清可识别该表位。然而,对28例活动性肺结核患者的血清进行分析后发现,12例(43%)患者也识别PDC-E2亚基(M2a),使用M2组分、纯化的PDC和重组PDC-E2进行蛋白质印迹分析可证明这一点。相比之下82例患有其他细菌和病毒感染的患者中(包括25例大肠杆菌感染患者),只有2例与70kD的PBC特异性表位发生反应。54%的肺结核患者和50%的其他感染性疾病患者存在天然存在的线粒体抗体(NOMA)。它们识别的是65kD(ε)或60/55kD(ζ/η)处的一个决定簇。100名献血者的血清中均无抗M2抗体,但有14人有NOMA。通过对来自分枝杆菌和大肠杆菌的膜组分进行蛋白质印迹分析来检测抗M2和NOMA阳性标记血清,结果表明,与哺乳动物线粒体一样,它们既含有PBC特异性M2抗原,也含有非PBC特异性的天然存在的线粒体抗原系统(NOMAg)。在患有分枝杆菌感染的患者中优先诱导产生PBC特异性抗体这一观察结果,可能为PBC病因仍不明的情况提供一些新线索。